Rhythm Pharmaceuticals, Inc.

NASDAQ:RYTM

49.01 (USD) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012
Revenue 77.42823.6383.154000000000
Cost of Revenue 9.3022.1330.5990.690.8340.4420.2230.1440000
Gross Profit 68.12621.5052.555-0.69-0.834-0.442-0.223-0.1440000
Gross Profit Ratio 0.880.910.81000000000
Reseach & Development Expenses 134.951108.63104.12890.45109.4550.33722.89419.5947.1485.2818.01515.678
General & Administrative Expenses 0000028.089.5186.3113.4251.2133.4332.46
Selling & Marketing Expenses 000000000000
SG&A 117.53292.03268.48646.12536.5528.089.5186.3113.4251.2133.4332.46
Other Expenses 0.19-0.79100000-1.8630-0.5000
Operating Expenses 252.483200.662172.614136.57514678.41732.41225.90510.5736.49321.44818.138
Operating Income -184.357-179.157-170.059-136.575-146-78.417-32.412-25.905-10.573-6.493-21.448-18.138
Operating Income Ratio -2.381-7.579-53.919000000000
Total Other Income Expenses Net 0.19-1.962100.4472.5795.2714.353-1.8630.033-0.500.0170.008
Income Before Tax -184.114-181.119-69.612-133.996-140.729-74.064-33.709-25.872-11.073-6.493-21.431-18.13
Income Before Tax Ratio -2.378-7.662-22.071000000000
Income Tax Expense 0.5641.962-1.605-3.269-6.1054.3531.07400000
Net Income -184.678-183.081-68.007-130.727-134.624-74.064-33.709-25.872-11.073-6.493-21.431-18.13
Net Income Ratio -2.385-7.745-21.562000000000
EPS -3.2-3.51-1.37-2.96-3.7-2.39-2.54-1.55-0.66-0.64-0.43-0.36
EPS Diluted -3.2-3.51-1.37-2.96-3.7-2.39-2.54-1.55-0.66-0.64-0.43-0.36
EBITDA -168.464-175.918-170.059-136.575-146-78.417-30.549-25.761-10.0730-21.428-18.121
EBITDA Ratio -2.176-7.442-53.919000000000